Supplant raised $15 million in a round led by Felicis Ventures.

Supplant, a London, UK-based producer of an alterntive type of sugar, announced completing a funding round of $15 million.

The money was raised from investors led by Felicis Ventures and included contributions from Coatue, Manta Ray Ventures, Khosla Ventures, and Y Combinator. The deal rounds up the money raised by the company to $24 million.

Supplant, founded as Cambridge Glycoscience in 2017 by CEO Tom Simmons, developed a biotechnology platform that makes sugar substitutes and based on which it produces sugars from the waste materials of plants other than sugarcane.

The company was part of Y Combinator in the summer of 2018.